Gain Therapeutics, Inc.

GANX·NASDAQ·$1.82Share Price as of 11/2·$78MMarket Cap as of 11/2

Financials

10-QQ2 ended 06/30/2608/11/26 10-QQ1 ended 03/31/2605/11/26 10-KFY 202503/26/26 10-QQ3 ended 09/30/2511/12/25 10-QQ2 ended 06/30/2508/12/25

Disclosures

8-KCurrent report10/28/26 8-KCurrent report10/01/26 8-KCurrent report09/28/26 8-KCurrent report08/11/26 8-KCurrent report07/16/26

Prospectuses and Registrations

S-8Registration of securities for employees12/03/25 424B5Prospectus supplement11/28/25 S-3/AShelf registration (amended)11/07/25 424B5Prospectus supplement07/17/25 424B5Prospectus supplement07/15/25

Proxies

DEF 14ADefinitive proxy04/28/26 DEFA14AAdditional proxy materials04/28/26 DEF 14ADefinitive proxy04/29/25 DEFA14AAdditional proxy materials04/29/25 PRE 14APreliminary proxy04/17/25

Ownership

Form 3Initial insider ownership10/30/26 Form 4Insider transaction10/30/26 Form 4Insider transaction07/17/26 Form 4Insider transaction07/17/26 Form 4Insider transaction07/17/26

Other

ARSAnnual report to shareholders04/28/26 UPLOADLetter from the SEC06/04/25 ARSAnnual report to shareholders04/29/25 ARSAnnual report to shareholders04/26/24 EFFECTRequest for effectiveness12/29/23